Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Gillman, L.M
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages
The first compared GLP-1 receptor agonist users with nonusers among patients with obesity but without type 2 diabetes
doi: 10.3389/fonc.2023.1100532 Received 16 November 2022 Accepted 06 February 2023 Published 24 February 2023 Volume 13 - 2023 Edited by Pierpaolo Alongi, ARNAS Ospedali Civico Di Cristina Benfratelli, Italy Reviewed by Vadim Byvaltsev, Irkutsk State Medical University, Russia
US$ 25.17
US$ 29.02
US$ 24.91
US$ 29.62
US$ 24.37
%25201.png)
US$ 26.96
US$ 28.51
